Concepedia

Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation

Hideaki Miyake, Toshifumi Kurahashi, Kazuki Yamanaka, Yutaka Kondo, Mototsugu Muramaki, Atsushi Takenaka, Takaaki Inoue, Masato Fujisawa

Urologic Oncology Seminars and Original Investigations · 2009 · 54 citations · 12 references

DOI

Concepts

References

12

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text

, , +11

In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.

Dirk B. Mendel, Alexander Laird, Xiaohua Xin et al. · PubMed · 2003 · 2K citations

, , +15

Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

Robert J. Motzer, Jennifer Bacik, Barbara A. Murphy et al. · Journal of Clinical Oncology · 2002 · 1.5K citations

, , +17

Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell Carcinoma

Robert J. Motzer · Journal of Clinical Oncology · 2002 · 608 citations

, , +17

Hypothyroidism after Sunitinib Treatment for Patients with Gastrointestinal Stromal Tumors

Jayesh Desai, Leila Yassa, Ellen Marqusee et al. · Annals of Internal Medicine · 2006 · 404 citations

, , +17